Locations:
Search IconSearch
October 16, 2024/Neurosciences/Podcast

Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

Parkinson’s disease is the most common form of parkinsonism, typically diagnosed through a combination of physical exam, medical history and symptoms. Atypical parkinsonian disorders, however, often follow more aggressive courses and can be more challenging to diagnose.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Whenever somebody follows a trajectory that looks different from Parkinson's disease, we call it atypical parkinsonism,” says Junaid Siddiqui, MD, a movement disorders specialist in Cleveland Clinic’s Center for Neuro-Restoration. “That would include earlier memory problems, earlier balance difficulties or falls, or significantly dysautonomia.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Siddiqui discusses the complexities of diagnosing and managing atypical parkinsonism. These disorders tend not to respond to levodopa (commonly prescribed for Parkinson’s disease) or show only short-lived, mild response.

Dr. Siddiqui describes primary symptoms of the following parkinsonian disorders:

  • Progressive supranuclear palsy (PSP)
  • Multiple system atrophy (MSA)
  • Corticobasal syndrome (CBD)
  • Dementia with Lewy bodies (DLB)

He also discusses an algorithm he developed with other movement disorder experts working with the CurePSP group to help general neurologists with patients they believe might have atypical parkinsonism.

To hear the 24-minute episode, click on the podcast player above. Or read on for a short, edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: So (let’s say) I'm getting a little bit older, I get a little mild tremor. I've kind of slowed down in my movements. I think I might have Parkinson's, I come and see you. How good are you at diagnosing Parkinson's disease?

Advertisement

Dr. Siddiqui: We have gotten good in picking up parkinsonism, especially in the movement disorder world. So that's how we start (parkinsonism). Whenever somebody comes in with a tremor, the first thing we notice is whether the tremor is symmetric or asymmetric, is it at rest or does it come out with use of hands? The handwriting size, has it become larger or smaller? Then we ask questions about a sense of smell or REM sleep behavior disorder and constipation. So we enquire about both non-motor symptoms and motor symptoms. We try to make a trajectory of when the symptoms started, how long it has been since the symptoms have begun and how severe they are. That gives us an idea of how aggressive the underlying condition is. Then we talk about the possibilities. If somebody has an asymmetric tremor at rest with micrographia, hyposmia, if they have REM sleep behavior disorder, constipation, and they've had these symptoms for the last four or five years, it is more likely to be Parkinson's disease rather than atypical parkinsonian disorder.

Dr. Stevens: How good are we at picking up the atypical disorders? Is it more difficult? Are there any ancillary tests that we can use? Does imaging help?

Dr. Siddiqui: Obtaining a good history is the most important thing that we can do. If you can get a history, the patient is trying to tell you what they have. So history gives us 80% or more of a diagnosis. So if somebody comes in with parkinsonism and they have falls before three years of disease onset, they have memory problems within a year of disease onset, they have severe dysautonomia … we already know that they have an atypical parkinsonian disorder. All we need to figure out if this is α-synucleinopathy or is it tauopathy? So α-synucleinopathies would be MSA or DLB. And tauopathies would be PSP and CBD.

Advertisement

Related Articles

Lewy body in neuron affected by Parkinson’s disease
October 31, 2024/Neurosciences/Brain Health
CSF Alpha-Synuclein Biomarker Strongly Associated With Clinical Features of Dementia With Lewy Bodies

Study provides Class III evidence that assay distinguishes disease from normal controls

Man on an exercise bicycle
October 29, 2024/Neurosciences/Research
New Parkinson’s Trial Focuses on Interplay Between Exercise and Genetics

Study aims to inform an enhanced approach to exercise as medicine

Dr. Mari in a clinical consultation with patient
October 23, 2024/Neurosciences/Brain Health
Practical Algorithm Helps Identify Atypical Parkinsonian Disorders

New tool for general neurologists aims to streamline differential diagnosis

24-NEU-4528160-genetics-parkinson-disease-650×450
Multi-Ancestry Genetic Study of Parkinson’s Disease Identifies New Risk Genes in Pursuit of Novel Treatment Targets

International collaboration is most genetically diverse study of the disease to date

23-NEU-4311758-CQD-Hero-650×450-PodcastButton
December 15, 2023/Neurosciences/Podcast
Palliative Care for Parkinson’s Disease (Podcast)

When and how a multidisciplinary palliative care clinic can fill unmet needs for this population

23-NEU-4085912-CQD-Hero1-Whole-650×450
Probing the Neural Mechanisms of Parkinson’s Disease Motor Dysfunction

Research project will leverage insights into neural circuits to advance DBS technology

illustration of two people taking a gait test wearing augmented reality headsets
Augmented Reality Platform Promises to Broaden Access to Dual-Task Training for Gait in PD

Randomized trial demonstrates noninferiority to therapist-led training

photo of old man with walker
Device-Aided Therapy Underutilized in Routine Care for Advanced Parkinson’s Disease

Study reveals heavy care burden, missed opportunities in patients with uncontrolled symptoms on oral therapy

Ad